← back to search

Yuhe Lei

Guangzhou University of Chinese Medicine · CN
Area of research
Molecular Biology · Epidemiology
Research interest
Research interests include Biology, Cancer research, Apoptosis, microRNA, Cancer, and Medicine.
h-index
citations
673
works
26
NIH funding
primary concept
email

Recent publications

Caffeic acid phenethyl ester induced apoptosis in chronic myeloid leukemia cells by inhibiting mitochondrial complex I
Scientific Reports 2026cited by 0position: middledoi
Genetically reprogrammed BMSCs with Lamin B1 depletion enhance bone regeneration for osteoporosis therapy
Frontiers in Bioengineering and Biotechnology 2026cited by 0position: middledoi
Erianin inhibits the proliferation and stemness of pancreatic cancer cells by interacting with MEK1/2
Biochemical Pharmacology 2025cited by 1position: middledoi
Xg-13, a derivate of marine natural product, exhibits anti-angiogenesis ability in hepatocellular carcinoma via inhibiting Axl signaling pathway
Biochemical Pharmacology 2025cited by 0position: middledoi
5-methylcytosine methylation of MALAT1 promotes resistance to sorafenib in hepatocellular carcinoma through ELAVL1/SLC7A11-mediated ferroptosis
Drug Resistance Updates 2024cited by 44position: middledoi
Replenishment of mitochondrial Na+ and H+ by ionophores potentiates cutaneous wound healing in diabetes
Materials Today Bio 2024cited by 7position: middledoi
Development and validation of a nomogram to predict overall survival in patients with glioma: a population-based study
Aging 2024cited by 1position: middledoi
Therapy resistance in neuroblastoma: Mechanisms and reversal strategies
Frontiers in Pharmacology 2023cited by 48position: lastdoi
Periplocin inhibits hepatocellular carcinoma progression and reduces the recruitment of MDSCs through AKT/NF-κB pathway
Life Sciences 2023cited by 23position: middledoi
Functions, mechanisms, and therapeutic implications of noncoding RNA in acute myeloid leukemia
Fundamental Research 2023cited by 11position: middledoi
Comprehensive analysis of the oncogenic and immunological role of FAP and identification of the ceRNA network in human cancers
Aging 2023cited by 4position: middledoi
Virtual screening combined with experimental verification reveals the potential mechanism of Fuzitang decoction against Gouty Arthritis
Heliyon 2023cited by 4position: middledoi
Shugan Jiangzhi Decoction Alleviates Nonalcoholic Fatty Liver Disease (NAFLD) <i>via</i> Regulating AMPK/PPAR Signaling Pathway
Letters in Drug Design & Discovery 2023cited by 2position: middledoi
Autophagy in Cancer Immunotherapy
Cells 2022cited by 54position: firstdoi
The MicroRNA-Based Strategies to Combat Cancer Chemoresistance via Regulating Autophagy
Frontiers in Oncology 2022cited by 25position: firstdoi
Evodiamine as the Active Compound of Evodiae fructus to Inhibit Proliferation and Migration of Prostate Cancer through PI3K/AKT/NF-κB Signaling Pathway
Disease Markers 2022cited by 24position: firstdoi
Circular RNAs in depression: Biogenesis, function, expression, and therapeutic potential
Biomedicine & Pharmacotherapy 2021cited by 47position: middledoi
New Insights Into the Regulatory Roles of Extracellular Vesicles in Tumor Angiogenesis and Their Clinical Implications
Frontiers in Cell and Developmental Biology 2021cited by 27position: middledoi
β-estradiol Induces Mitochondrial Apoptosis in Cervical Cancer through the Suppression of AKT/NF-κB Signaling Pathway
Recent Patents on Anti-Cancer Drug Discovery 2021cited by 6position: middledoi
Bioinformatics and Network Pharmacology-Based Approaches to Explore the Potential Mechanism of the Antidepressant Effect of Cyperi Rhizoma through Soothing the Liver
Evidence-based Complementary and Alternative Medicine 2021cited by 5position: firstdoi
Natural products and their derivatives: Promising modulators of tumor immunotherapy
Journal of Leukocyte Biology 2020cited by 188position: middledoi
MicroRNAs target the Wnt/β‑catenin signaling pathway to regulate epithelial‑mesenchymal transition in cancer (Review)
Oncology Reports 2020cited by 51position: firstdoi
Molecular mechanisms of bufadienolides and their novel strategies for cancer treatment
European Journal of Pharmacology 2020cited by 45position: middledoi
Digitoxin inhibits HeLa cell growth through the induction of G2/M cell cycle arrest and apoptosis in vitro and in vivo
International Journal of Oncology 2020cited by 23position: middledoi
1β–OH–arenobufagin induces mitochondrial apoptosis in hepatocellular carcinoma through the suppression of mTOR signaling pathway
Journal of Ethnopharmacology 2020cited by 19position: middledoi
Digitoxin inhibits proliferation of multidrug‑resistant HepG2 cells through G2/M cell cycle arrest and apoptosis
Oncology Letters 2020cited by 14position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Lijuan Deng · Sun Yat-sen University Cancer Center12 papers (2020–2025)Enxin Zhang · Guangzhou University of Chinese Medicine7 papers (2020–2022)Ming Qi · Fudan University6 papers (2020–2025)Jiaxu Chen · Guangzhou University of Chinese Medicine5 papers (2020–2021)Yinqin Zhong · Guangzhou University of Chinese Medicine5 papers (2021–2022)Junshan Liu · Guangzhou University of Chinese Medicine5 papers (2020–2023)Wen‐Cai Ye · Shandong University4 papers (2020–2023)Dongmei Zhang · Cleveland Clinic4 papers (2020–2020)Hua Gan · Nanchang University3 papers (2020–2022)Mei-Ching Chan · Jinan University3 papers (2021–2023)Chiwing Chung · Jinan University3 papers (2021–2023)Yuqing Huang · Sun Yat-sen University Cancer Center3 papers (2020–2023)Lei Chen · Hebei Medical University3 papers (2020–2021)Xiaokang Wang · University of California, Davis3 papers (2023–2024)Yueyue Chen · Sichuan University2 papers (2020–2023)Man-Si Wu · Guangdong Food Industry Research Institute2 papers (2020–2021)Qingyu Ma · Guangzhou University of Chinese Medicine2 papers (2020–2021)Maohua Huang · Jinan University2 papers (2021–2023)Minfeng Chen · Jinan University2 papers (2023–2025)Yanli Fu · Guangzhou University of Chinese Medicine2 papers (2021–2023)